Hill-Rom Stock Analysis (NYSE:HRC)

Add to My Stocks
$83.48 $0.01 (0.01%) HRC stock closing price Jul 20, 2017 (Closing)
Watch Robo Advisor Video of HRC Stock Analysis
Hill-Rom
Updated on : Jul 20, 2017
previous close
HRC 83.5 (0%)
S&P 500 2473.5 (0%)
Closing Price On: Jul 20, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Products
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q2
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
10.1%
Sector Average:
-0.5%
5 Quarter Net Profit
Net Margins
2017-Q2
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
2.4B
Debt/Equity Ratio:
 1.92
Compared to the industry
Cash Flow
Operating cash flow:
$55.4M
Net Income:
$34.4M
Dividend Yield
HRC dividend yield:
0.83%
PROS      CONS
Operating Margins
Net Margins
Cash Flow
ROIC
ROE
FCF Margin
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
HRC PS :
2.1
Industry PS :
5.2
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
6.9%
Return on Equity:
12.8%
Free Cash Flow Margin:
5.4%
Double Tap To Exit Full Screen
0:00
/

Hill-Rom Analysis Video

65 5 2

View Hill-Rom stock analysis video. This is our HRC analyst opinion covering the buy and sell arguments for HRC stock.

Hill-Rom Holdings, Inc. Stock Rating (3.6/5)

Our Hill-Rom stock opinion is based on fundamentals of the company. This Hill-Rom stock analysis is based on latest Q2 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy HRC stock?

  • Hill-Rom's average operating margin of 10.1% was exceptional.
  • Net margins came in at average 5.8% for Hill-Rom over the last twelve months.
  • The company has an operating cash flow which is 1.6 times the net income. We see this as a positive signal.
  • When compared with the Medical Products industry average PS ratio of 5.2, the price-to-sales ratio of 2.1 for HRC stock is attractive.
  • Hill-Rom has an attractive ROIC (Return on Invested Capital) of 6.9%
  • Return On Equity (ROE) which is a measure of the company's profitability, looks great for Hill-Rom at 12.8%.
  • The company has a healthy free cash flow margin of 5.4%.

Should you sell HRC stock?

  • Hill-Rom has a debt/equity ratio of  1.92, which is worse than the average in the Medical sector.

Comments on this video and Hill-Rom stock